The results of this assay revealed that Rictor silencing enhanced the number of melanoma cells in G2/M phase and reduced the number of G0/S‐phase cells (Fig. 3B; shRictor#1 results as Fig. S2A). The gene discussed is RICTOR; the disease is melanoma.